Zurzuvae, the New Postpartum Depression Drug Now Available in the U.S. - This is How Insurers Have Responded
Zurzuvae™, the new first-of-its-kind 14-day postpartum depression pill, became available in the U.S. yesterday. Zurzuvae is a pill that is taken for 14 days and has been shown to provide rapid improvements in depressive symptoms by day 15, and as early as day 3, according to the drug’s developer, Sage Therapeutics. This is a substantive improvement over the 4-6 weeks to potentially see improvement with standard depression drug treatments.[1]
Read More